Richa Poddar - 14 Feb 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Chief Commercial Officer
Signature: /s/ William Cook, as Attorney in Fact for Richa Poddar
Issuer symbol: AGIO
Transactions as of: 14 Feb 2022
Net transactions value: -$17,995
Form type: 4
Filing time: 16 Feb 2022, 16:00:58 UTC
Previous filing: 14 Feb 2022
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+1,738	+116%	$0.000000	3,231	14 Feb 2022	Direct	F1
transaction	AGIO	Common stock	Tax liability	$17,995	-590	-18%	$30.50	2,641	14 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-1,738	-50%	$0.000000	1,738	14 Feb 2022	Common stock	1,738		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2	The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.